131 related articles for article (PubMed ID: 3125986)
1. Effect of interleukin 2 on fetal thymocytes in organ cultures: generation of lymphokine-activated killer cells.
Skinner M; Marbrook J
Cell Immunol; 1988 Mar; 112(1):104-11. PubMed ID: 3125986
[TBL] [Abstract][Full Text] [Related]
2. Development of fetal thymocytes in organ cultures. Effect of interleukin 2.
Skinner M; Le Gros G; Marbrook J; Watson JD
J Exp Med; 1987 Jun; 165(6):1481-93. PubMed ID: 3108443
[TBL] [Abstract][Full Text] [Related]
3. Development of thymocytes in organ culture: migrant cells with natural killer cell characteristics.
Skinner MA; Moffatt L; Marbrook J
Immunol Cell Biol; 1989 Apr; 67 ( Pt 2)():107-14. PubMed ID: 2786495
[TBL] [Abstract][Full Text] [Related]
4. Ontogeny of proliferative and cytotoxic responses to interleukin 2 and concanavalin A in murine fetal thymus.
Teh HS; Ho M
J Immunol; 1985 Mar; 134(3):1653-8. PubMed ID: 3871454
[TBL] [Abstract][Full Text] [Related]
5. IL-4 regulation of murine lymphokine-activated killer activity in vitro. Effects on the IL-2-induced expansion, cytotoxicity, and phenotype of lymphokine-activated killer effectors.
Mulé JJ; Krosnick JA; Rosenberg SA
J Immunol; 1989 Jan; 142(2):726-33. PubMed ID: 2783444
[TBL] [Abstract][Full Text] [Related]
6. Alloantigen-induced cytotoxicity against syngeneic tumor cells: analysis at the clonal level.
Sensi M; Orosz CG; Bach FH
J Immunol; 1984 Jun; 132(6):3218-25. PubMed ID: 6202778
[TBL] [Abstract][Full Text] [Related]
7. In vivo generation of lymphokine-activated killer cells by sensitization with interleukin 2-producing syngeneic T-lymphoma cells.
Nishimura T; Uchiyama Y; Hashimoto Y
Cell Immunol; 1988 Mar; 112(1):220-5. PubMed ID: 3125989
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
LeFor AT; Eisenthal A; Rosenberg SA
J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of thymocytes in fetal organ culture: analysis of phenotypic changes accompanying the appearance of cytolytic and interleukin 2-producing cells.
Kisielow P; Leiserson W; Von Boehmer H
J Immunol; 1984 Sep; 133(3):1117-23. PubMed ID: 6611365
[TBL] [Abstract][Full Text] [Related]
10. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
[TBL] [Abstract][Full Text] [Related]
11. Degradation of specificity in cytolytic T lymphocyte clones. The separate YAC-1-type (NK-like) and P815-type broad specificity killing patterns are both restricted to the larger cells within a clone but may be expressed independently in clones from different mouse strains.
Shortman K; Wilson A
J Immunol; 1986 Aug; 137(3):798-804. PubMed ID: 2424983
[TBL] [Abstract][Full Text] [Related]
12. Anti-Thy-1 plus complement-treated, cultured bone marrow cells resemble fetal thymocytes in killer cell function and marker expression.
Hurwitz JL; McAndrew EC; Doherty PC
J Immunol; 1986 Sep; 137(6):1757-63. PubMed ID: 2875109
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killer cells: lysis of fresh syngeneic natural killer-resistant murine tumor cells by lymphocytes cultured in interleukin 2.
Rosenstein M; Yron I; Kaufmann Y; Rosenberg SA
Cancer Res; 1984 May; 44(5):1946-53. PubMed ID: 6608989
[TBL] [Abstract][Full Text] [Related]
14. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
Gray JD; Torten M; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine-activated killer (LAK) cells. III. Characterization of LAK precursors and susceptible target cells within the murine thymus.
Ballas ZK; Rasmussen W
J Immunol; 1987 Nov; 139(10):3542-9. PubMed ID: 3500221
[TBL] [Abstract][Full Text] [Related]
16. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
Owen-Schaub LB; Gutterman JU; Grimm EA
Cancer Res; 1988 Feb; 48(4):788-92. PubMed ID: 3257408
[TBL] [Abstract][Full Text] [Related]
17. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
18. Generation of nonspecific murine cytotoxic T cells in vitro by purified human interleukin 2.
Merluzzi VJ; Savage DM; Mertelsmann R; Welte K
Cell Immunol; 1984 Mar; 84(1):74-84. PubMed ID: 6199125
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and functional heterogeneity of thymic and splenic lymphokine activated killer cells relative to ornithine sensitivity.
Mehrotra P; Bear HD; Susskind BM
Cell Immunol; 1991 Feb; 132(2):451-65. PubMed ID: 1899052
[TBL] [Abstract][Full Text] [Related]
20. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
